「nov」の検索結果
20件：11～15件目を表示
-
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
erseas The 17th Joint Meeting of Japan-Korea-China Ophthalmologists 開催日：2024年11月9日 開催地：コングレスクエア羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Place...
http://www.senju.co.jp/english/rd/society/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
と見る 海外 The 17th Joint Meeting of Japan-Korea-China Ophthalmologists 開催日：2024年11月9日 開催地：コングレスクエア羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Place...
https://www.senju.co.jp/rd/society/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
erseas The 17th Joint Meeting of Japan-Korea-China Ophthalmologists 開催日：2024年11月9日 開催地：コングレスクエア羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Place...
https://www.senju.co.jp/english/rd/society/ -
nical Trials in Japan for “SJP-0132” for the treatment of Dry Eye Disease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquart...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322_0.pdf -
お知らせ | 千寿製薬株式会社
January 17, 2025 Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132（PDF） November 26, 2024 Launch and Distribution of “MIEr for Image...
http://www.senju.co.jp/english/news/